Platelet Rich Plasma in Erectile Dysfunction A Double-Blind, Randomized, Placebo-Controlled Clinical Trial

Abstract

Background: The studies postulate that platelet-rich plasma (PRP) injections improve key elements of neovascualrity to erectile dysfunction (ED).Aim: Double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of PRP injections in patients with mild and moderate ED. Exclusion criteria were patient undergo sever EDMethods: Study is accomplished in Alnuman teaching hospital 2019 and 2022 over 59 patients were complaining mild to moderate ED, four sessions of P-shot 2 weeks apart each session.Results: In period 3, 6 months’ interval, a response was achieved by 35/42 (83%) patients in the PRP group compared to 5/17 (29%) in the placebo group.Key words: Platelet rich plasma, erectile dysfunction, p-shot, intracavernosal injection.